Letter: Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery. Liu FS, Zou MX, Li J. Neurosurgery 2022;90:e19.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu FS, Zou MX, Li J. Letter: Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery. Neurosurgery 2022;90:e19.
PMID: 34982891